Lindsay Mark F. reported VVOS

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001493152-26-048621

Machine-readable

Structured copy

Timestamps

Event (reported)

Sep 14, 2026

Published

Oct 26, 2026

Ingested by INSIDER

Nov 5, 02:09 UTC

Last re-read

Nov 5, 02:09 UTC

Extracted facts

Filer

Lindsay Mark F.

Role

Director

Transaction

Grant or awardAs filed: “A”

Asset

Vivos Therapeutics, Inc. — Stock Options (Right to Buy)

Ticker

VVOS

Shares

12.0K

Price per share

$0

Execution date (reported)

Sep 14, 2026

Owned after transaction

17.2K shares

Days from execution to publication

42

What this establishes

Lindsay Mark F. filed this Form 4 reporting a grant or award of VVOS on Sep 14, 2026. It became public on Oct 26, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director

Lindsay Mark F.cik:0001835542

Issuer

Vivos Therapeutics, Inc.cik:0001716166

Revision history · 0

No field has changed since this record was first ingested.